Benny Sorensen
Founder & CEO · Hemab Therapeutics · Cambridge, Massachusetts, United States
Biotechnology Research · Series C · Founded 2020
Latest raise
$157M
Date raised
October 27, 2025
Round
Series C
About Benny Sorensen
Hemab is pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
- Who is Benny Sorensen?
- Benny Sorensen is listed as Founder & CEO of Hemab Therapeutics, a biotechnology research company founded in 2020 based in Cambridge, Massachusetts, United States.
- How much did Hemab Therapeutics raise?
- Hemab Therapeutics raised $157M in a Series C round on October 27, 2025 (371 days ago). Backed by Sofinnova Partners.
Get newly funded founders every week
A free weekly list of startups that just raised.